David Windley
Stock Analyst at UBS
(3.64)
# 818
Out of 5,090 analysts
199
Total ratings
67.26%
Success rate
14.45%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgrades: Buy | $253 → $313 | $257.85 | +21.39% | 19 | Dec 5, 2025 | |
| DEO Diageo | Downgrades: Neutral | n/a | $88.46 | - | 1 | Dec 3, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $317 → $409 | $330.91 | +23.60% | 27 | Oct 17, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $548.12 | -17.90% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $225.85 | -0.38% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $185.80 | -5.81% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $14.24 | -33.29% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $184.31 | +5.80% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $263.28 | -0.11% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.39 | +97.84% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $38.34 | +59.10% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $16.77 | -28.44% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $265.44 | +58.98% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $151.86 | +95.57% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.81 | +364.28% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $330.75 | +82.62% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $575.34 | -34.82% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $16.75 | -7.46% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $242.00 | +11.57% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.22 | +68.11% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $280.23 | +91.27% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $22.11 | +31.16% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.59 | +3,167.46% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.36 | - | 5 | Oct 9, 2017 |
Humana
Dec 5, 2025
Upgrades: Buy
Price Target: $253 → $313
Current: $257.85
Upside: +21.39%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $88.46
Upside: -
UnitedHealth Group
Oct 17, 2025
Maintains: Buy
Price Target: $317 → $409
Current: $330.91
Upside: +23.60%
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $548.12
Upside: -17.90%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $225.85
Upside: -0.38%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $185.80
Upside: -5.81%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $14.24
Upside: -33.29%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $184.31
Upside: +5.80%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $263.28
Upside: -0.11%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.39
Upside: +97.84%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $38.34
Upside: +59.10%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $16.77
Upside: -28.44%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $265.44
Upside: +58.98%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $151.86
Upside: +95.57%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.81
Upside: +364.28%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $330.75
Upside: +82.62%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $575.34
Upside: -34.82%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $16.75
Upside: -7.46%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $242.00
Upside: +11.57%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.22
Upside: +68.11%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $280.23
Upside: +91.27%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $22.11
Upside: +31.16%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.59
Upside: +3,167.46%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.36
Upside: -